BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhu F, Li C, Chu F, Tian X, Zhu J. Target Dysbiosis of Gut Microbes as a Future Therapeutic Manipulation in Alzheimer's Disease. Front Aging Neurosci 2020;12:544235. [PMID: 33132894 DOI: 10.3389/fnagi.2020.544235] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Lee DY, Shin YJ, Kim JK, Jang HM, Joo MK, Kim DH. Alleviation of cognitive impairment by gut microbiota lipopolysaccharide production-suppressing Lactobacillus plantarum and Bifidobacterium longum in mice. Food Funct 2021;12:10750-63. [PMID: 34608923 DOI: 10.1039/d1fo02167b] [Reference Citation Analysis]
2 Milenkovic D, Capel F, Combaret L, Comte B, Dardevet D, Evrard B, Guillet C, Monfoulet LE, Pinel A, Polakof S, Pujos-Guillot E, Rémond D, Wittrant Y, Savary-Auzeloux I. Targeting the gut to prevent and counteract metabolic disorders and pathologies during aging. Crit Rev Food Sci Nutr 2022;:1-26. [PMID: 35730212 DOI: 10.1080/10408398.2022.2089870] [Reference Citation Analysis]
3 de Rijke TJ, Doting MHE, van Hemert S, De Deyn PP, van Munster BC, Harmsen HJM, Sommer IEC. A Systematic Review on the Effects of Different Types of Probiotics in Animal Alzheimer's Disease Studies. Front Psychiatry 2022;13:879491. [DOI: 10.3389/fpsyt.2022.879491] [Reference Citation Analysis]
4 Chi L, Cheng X, Lin L, Yang T, Sun J, Feng Y, Liang F, Pei Z, Teng W. Porphyromonas gingivalis-Induced Cognitive Impairment Is Associated With Gut Dysbiosis, Neuroinflammation, and Glymphatic Dysfunction. Front Cell Infect Microbiol 2021;11:755925. [PMID: 34926316 DOI: 10.3389/fcimb.2021.755925] [Reference Citation Analysis]
5 Snyder LM, Denkers EY. From Initiators to Effectors: Roadmap Through the Intestine During Encounter of Toxoplasma gondii With the Mucosal Immune System. Front Cell Infect Microbiol 2020;10:614701. [PMID: 33505924 DOI: 10.3389/fcimb.2020.614701] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Shi M, Chu F, Tian X, Aerqin Q, Zhu F, Zhu J. Role of Adaptive Immune and Impacts of Risk Factors on Adaptive Immune in Alzheimer's Disease: Are Immunotherapies Effective or Off-Target? Neuroscientist 2021;:1073858420987224. [PMID: 33530843 DOI: 10.1177/1073858420987224] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Białecka-Dębek A, Granda D, Szmidt MK, Zielińska D. Gut Microbiota, Probiotic Interventions, and Cognitive Function in the Elderly: A Review of Current Knowledge. Nutrients 2021;13:2514. [PMID: 34444674 DOI: 10.3390/nu13082514] [Reference Citation Analysis]
8 Wang XQ, Li H, Li XN, Yuan CH, Zhao H. Gut-Brain Axis: Possible Role of Gut Microbiota in Perioperative Neurocognitive Disorders. Front Aging Neurosci 2021;13:745774. [PMID: 35002672 DOI: 10.3389/fnagi.2021.745774] [Reference Citation Analysis]
9 Frausto DM, Forsyth CB, Keshavarzian A, Voigt RM. Dietary Regulation of Gut-Brain Axis in Alzheimer's Disease: Importance of Microbiota Metabolites. Front Neurosci 2021;15:736814. [PMID: 34867153 DOI: 10.3389/fnins.2021.736814] [Reference Citation Analysis]
10 Banerjee A, Pradhan LK, Sahoo PK, Jena KK, Chauhan NR, Chauhan S, Das SK. Unravelling the potential of gut microbiota in sustaining brain health and their current prospective towards development of neurotherapeutics. Arch Microbiol 2021;203:2895-910. [PMID: 33763767 DOI: 10.1007/s00203-021-02276-9] [Reference Citation Analysis]
11 Shi M, Chu F, Zhu F, Zhu J. Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer’s Disease: A Focus on Aducanumab and Lecanemab. Front Aging Neurosci 2022;14:870517. [DOI: 10.3389/fnagi.2022.870517] [Reference Citation Analysis]
12 Sharma VK, Singh TG, Garg N, Dhiman S, Gupta S, Rahman MH, Najda A, Walasek-Janusz M, Kamel M, Albadrani GM, Akhtar MF, Saleem A, Altyar AE, Abdel-Daim MM. Dysbiosis and Alzheimer's Disease: A Role for Chronic Stress? Biomolecules 2021;11:678. [PMID: 33946488 DOI: 10.3390/biom11050678] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
13 Fulop T, Tripathi S, Rodrigues S, Desroches M, Bunt T, Eiser A, Bernier F, Beauregard PB, Barron AE, Khalil A, Plotka A, Hirokawa K, Larbi A, Bocti C, Laurent B, Frost EH, Witkowski JM. Targeting Impaired Antimicrobial Immunity in the Brain for the Treatment of Alzheimer's Disease. Neuropsychiatr Dis Treat 2021;17:1311-39. [PMID: 33976546 DOI: 10.2147/NDT.S264910] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Onyango IG, Jauregui GV, Čarná M, Bennett JP Jr, Stokin GB. Neuroinflammation in Alzheimer's Disease. Biomedicines 2021;9:524. [PMID: 34067173 DOI: 10.3390/biomedicines9050524] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lauretani F, Longobucco Y, Maggio M. Gut microbiota and motoric-cognitive frailty in hospitalized older persons. Curr Opin Clin Nutr Metab Care 2021;24:209-15. [PMID: 33587364 DOI: 10.1097/MCO.0000000000000739] [Reference Citation Analysis]
16 Gonçalves PB, Sodero ACR, Cordeiro Y. Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases. Biomolecules 2021;11:767. [PMID: 34065606 DOI: 10.3390/biom11050767] [Reference Citation Analysis]